These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 31761832

  • 1. [Relationship between striatal 123I-FP-CIT uptake and cognitive functions in Parkinson's disease].
    Sawada H, Orimo S.
    Rinsho Shinkeigaku; 2019 Dec 25; 59(12):799-805. PubMed ID: 31761832
    [Abstract] [Full Text] [Related]

  • 2. Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.
    Kübler D, Schroll H, Buchert R, Kühn AA.
    J Neural Transm (Vienna); 2017 Sep 25; 124(9):1073-1081. PubMed ID: 28643101
    [Abstract] [Full Text] [Related]

  • 3. Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT.
    Neishi H, Ikawa M, Okazawa H, Tsujikawa T, Arishima H, Kikuta KI, Yoneda M.
    Eur Neurol; 2017 Sep 25; 78(3-4):161-168. PubMed ID: 28848099
    [Abstract] [Full Text] [Related]

  • 4. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
    Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA, Stoof JC, Wolters EC.
    J Nucl Med; 1998 Jul 25; 39(7):1143-8. PubMed ID: 9669384
    [Abstract] [Full Text] [Related]

  • 5. Striatal dopamine transporters and cognitive function in Parkinson's disease.
    Stögbauer J, Rosar F, Dillmann U, Faßbender K, Ezziddin S, Spiegel J.
    Acta Neurol Scand; 2020 Oct 25; 142(4):385-391. PubMed ID: 32914881
    [Abstract] [Full Text] [Related]

  • 6. Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease.
    Rektorova I, Srovnalova H, Kubikova R, Prasek J.
    Mov Disord; 2008 Aug 15; 23(11):1580-7. PubMed ID: 18618663
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
    Park SB, Kwon KY, Lee JY, Im K, Sunwoo JS, Lee KB, Roh H, Ahn MY, Park S, Kim SJ, Oh JS, Kim JS.
    Neurol Sci; 2019 Feb 15; 40(2):311-317. PubMed ID: 30415448
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson's disease - the PPMI cohort.
    Nicastro N, Garibotto V, Burkhard PR.
    BMC Neurol; 2020 May 16; 20(1):192. PubMed ID: 32416724
    [Abstract] [Full Text] [Related]

  • 14. Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake.
    Benamer HT, Patterson J, Wyper DJ, Hadley DM, Macphee GJ, Grosset DG.
    Mov Disord; 2000 Jul 16; 15(4):692-8. PubMed ID: 10928580
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Smoking in Patients with Parkinson's Disease: preliminary striatal DaT-SPECT findings.
    Gigante AF, Defazio G, Niccoli Asabella A, Superbo M, Ferrari C, Liuzzi D, Iliceto G, Livrea P, Rubini G.
    Acta Neurol Scand; 2016 Oct 16; 134(4):265-70. PubMed ID: 26659996
    [Abstract] [Full Text] [Related]

  • 17. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
    Di Giuda D, Calcagni ML, Totaro M, Cocciolillo F, Piano C, Soleti F, Fasano A, Cioni B, Bentivoglio AR, Giordano A.
    Nucl Med Commun; 2012 Sep 16; 33(9):933-40. PubMed ID: 22735298
    [Abstract] [Full Text] [Related]

  • 18. Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.
    Pilotto A, Schiano di Cola F, Premi E, Grasso R, Turrone R, Gipponi S, Scalvini A, Cottini E, Paghera B, Garibotto V, Rizzetti MC, Bonanni L, Borroni B, Morbelli S, Nobili F, Guerra UP, Perani D, Padovani A.
    Eur J Nucl Med Mol Imaging; 2019 Jul 16; 46(8):1642-1651. PubMed ID: 31098748
    [Abstract] [Full Text] [Related]

  • 19. Analysis of Extrastriatal 123I-FP-CIT Binding Contributes to the Differential Diagnosis of Parkinsonian Diseases.
    Joling M, Vriend C, van den Heuvel OA, Raijmakers PGHM, Jones PA, Berendse HW, Booij J.
    J Nucl Med; 2017 Jul 16; 58(7):1117-1123. PubMed ID: 27856628
    [Abstract] [Full Text] [Related]

  • 20. Clinical impact of correlative [123I]-FP-CIT brain imaging and neurological findings in suspect Parkinson's disease.
    Covelli EM, Brunetti A, Di Lauro A, Sullo P, Mazzarella G, Tedeschi E, Belfiore G.
    Radiol Med; 2004 Oct 16; 108(4):417-25. PubMed ID: 15525895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.